Una investigación liderada por Joan A. Barberà del Hospital Clinic de Barcelona-IDIBAPS e investigador principal del CIBER del área de Enfermedades Respiratorias (CIBERES), y en la que han particip...
Read moreLa Universitat Politècnica de València (UPV) y la Conselleria de Sanidad, a través de la Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (Fisabio),...
Read moreInitiatives seek to advance remote health monitoring, create an oral drug for Inflammatory Bowel Disease, and enhance 13C magnetic resonance imaging for therapeutic research. Leveraging cutting-edge t...
Read moreIt has been validated a new methodology to identify cancer-inducing genetic variations, known as drivers, through the analysis of gene copy increase in preclinical organoid models.
Read moreResult show that adding immune checkpoint inhibitor atezolizumab to standard of care with bevacizumab and chemotherapy significantly improves progression-free survival and overall survival in patients...
Read moreThe ibs.GRANADA is pleased to announce the approval of an ambitious European project funded with more than 600,000 euros by the European Union to improve the health of children and reduce the economic...
Read moreAn international team of researchers from the Institute for Research in Biomedicine (IRB Barcelona), the Max Planck Institute for Molecular Genetics (MPIMG), BC Cancer (University of British Columbia)...
Read moreThe UAB has launched a new campaign to raise funds to study a gene therapy for adenylsuccinate lyase deficiency (ADSL), a rare genetic disease suffered by about 80 children in the world, including two...
Read moreUn estudio liderado por un grupo de investigación de la URV-IISPV-CIBEROBN detecta esta relación en personas de edad avanzada con riesgo cardiovascular
Read moreGenes give instructions for the functioning of the body. We now know that each of those instructions is read by cells at a certain time of day, to adapt to the Earth’s light/dark cycle.
Read moreIt has beed used innovative strategies to redirect cellular degradation and thus eliminate proteins that cause various diseases.
Read moreThe Association has awarded Oryzon a 498,690 USD grant through its Lawrence and Isabel Barnett Drug Development Program to support the regulatory preclinical development of ORY-4001, a highly selectiv...
Read more